Literature DB >> 31650968

Hyperintensity at fat spared area in steatotic liver on the hepatobiliary phase MRI.

Emre Ünal1, İlkay Sedakat İdilman1, Ali Devrim Karaosmanoğlu1, Mustafa Nasuh Özmen1, Deniz Akata1, Muşturay Karcaaltıncaba1.   

Abstract

PURPOSE: We aimed to investigate the reasons for hyperintensity at fat spared area in steatotic liver at hepatobiliary phase (HBP) on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) enhanced liver magnetic resonance imaging.
METHODS: Twenty-two patients with focal fat spared area demonstrating hyperintensity on HBP images were included. A region of interest was placed on in- and opposed-phase images at fat spared area and liver to measure the fat. The measurement was also performed on precontrast T1-weighted and HBP images. The signal intensities of spleen, kidney, muscle, intervertebral disc, and spinal cord were also recorded.
RESULTS: The mean fat fraction of liver and fat spared area was 24.86% (8%-46%) and 8.41% (1%-34%), respectively (P < 0.001). There was a significant positive correlation between liver parenchyma fat fraction and delta fat fraction (r=0.74, P < 0.001). The mean signal intensity values of fat spared areas were higher compared with liver on precontrast T1-weighted and HBP images (P < 0.001). The mean relative enhancement ratio of liver and fat spared areas were 0.98 (0.05-1.90) and 1.15 (0.22-2.03), respectively (P < 0.001). However, in 6 patients, the relative enhancement ratio of liver and fat spared areas were almost equal. The uptake of Gd-EOB at fat spared area was not correlated with the degree of steatosis (r = -0.01, P = 0.95).
CONCLUSION: Fat spared area in steatotic liver appears hyperintense on HBP images due to increased relative enhancement ratio and/or baseline hyperintensity on precontrast images.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31650968      PMCID: PMC6837304          DOI: 10.5152/dir.2019.18535

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  26 in total

1.  Liver analysis using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: Correlation with histological grading and quantitative liver evaluation prior to hepatectomy.

Authors:  Keigo Kumazawa; Yoshihiro Edamoto; Mikio Yanase; Tomohiro Nakayama
Journal:  Hepatol Res       Date:  2012-05-31       Impact factor: 4.288

Review 2.  Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI.

Authors:  Ceyla Basaran; Musturay Karcaaltincaba; Deniz Akata; Nevzat Karabulut; Devrim Akinci; Mustafa Ozmen; Okan Akhan
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

Review 3.  Liver Function Assessment by Magnetic Resonance Imaging.

Authors:  Emre Ünal; Deniz Akata; Musturay Karcaaltincaba
Journal:  Semin Ultrasound CT MR       Date:  2016-08-17       Impact factor: 1.875

4.  Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT.

Authors:  Vivian Y Park; Jin-Young Choi; Yong Eun Chung; Honsoul Kim; Mi-Suk Park; Joon Seok Lim; Ki Whang Kim; Myeong-Jin Kim
Journal:  Liver Int       Date:  2014-04-10       Impact factor: 5.828

5.  Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography.

Authors:  Daisuke Kakihara; Akihiro Nishie; Noboru Harada; Ken Shirabe; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Tomohiro Nakayama; Yukihisa Takayama; Daisuke Okamoto; Nobuhiro Fujita; Junji Kishimoto; Hiroshi Honda
Journal:  J Magn Reson Imaging       Date:  2013-11-20       Impact factor: 4.813

6.  Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis C by EOB-MRI.

Authors:  Shunsuke Nojiri; Kei Fujiwara; Noboru Shinkai; Mio Endo; Takashi Joh
Journal:  World J Hepatol       Date:  2014-12-27

7.  Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis.

Authors:  H Nilsson; L Blomqvist; L Douglas; A Nordell; I Janczewska; E Näslund; E Jonas
Journal:  Br J Radiol       Date:  2013-02-12       Impact factor: 3.039

8.  Usefulness of Gd-EOB-DTPA-enhanced MR imaging in the evaluation of simple steatosis and nonalcoholic steatohepatitis.

Authors:  Zhuo Wu; Osamu Matsui; Azusa Kitao; Kazuto Kozaka; Wataru Koda; Satoshi Kobayashi; Yasuji Ryu; Tetsuya Minami; Junichiro Sanada; Toshifumi Gabata
Journal:  J Magn Reson Imaging       Date:  2012-11-21       Impact factor: 4.813

9.  New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.

Authors:  Natsuko Tsuda; Masahiro Okada; Takamichi Murakami
Journal:  Eur J Radiol       Date:  2008-11-20       Impact factor: 3.528

10.  Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

Authors:  José Traila Campos; Claude B Sirlin; Jin-Young Choi
Journal:  Insights Imaging       Date:  2012-06-15
View more
  2 in total

Review 1.  Benign focal liver lesions: The role of magnetic resonance imaging.

Authors:  Marco Gatti; Cesare Maino; Davide Tore; Andrea Carisio; Fatemeh Darvizeh; Eleonora Tricarico; Riccardo Inchingolo; Davide Ippolito; Riccardo Faletti
Journal:  World J Hepatol       Date:  2022-05-27

Review 2.  Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting.

Authors:  Federica Vernuccio; Domenico Salvatore Gagliano; Roberto Cannella; Ahmed Ba-Ssalamah; An Tang; Giuseppe Brancatelli
Journal:  Insights Imaging       Date:  2021-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.